Logo
Back to models
QIN-BREAST
This dataset contains longitudinal PET/CT and quantitative MR images collected for the purpose of studying treatment assessment in breast cancer in the neoadjuvant setting.
dataset2026-09-1558195575
51

Overview

Schema Version

https://atlas.rsna.org/schemas/2025-11/dataset.json

Name

QIN-BREAST

Link

https://www.cancerimagingarchive.net/?s=QIN-BREAST

Indexing

Keywords: Breast cancer, Neoadjuvant therapy, Treatment assessment, Quantitative imaging, Longitudinal study, PET/CT, MRI, Diffusion-weighted imaging, Dynamic contrast-enhanced MRI, T1-mapping
Content: BR, CA, CT, MR, NM

Author(s)

Li, X.
Abramson, R. G.
Arlinghaus, L. R.
Chakravarthy, A. B.
Abramson, V. G.
Sanders, M.
Yankeelov, T. E.

Organization(s)

Vanderbilt University
The Cancer Imaging Archive (TCIA)

Version

2

License

Text: CC BY 3.0
URL: https://creativecommons.org/licenses/by/3.0/

Contact

TCIA's Helpdesk

Funding

The NCI Quantitative Imaging Network (QIN)

Comments

This collection contains longitudinal PET/CT and quantitative MR images collected for the purpose of studying treatment assessment in breast cancer in the neoadjuvant setting. Images were acquired at three time points: prior to the start of treatment (t1), after the first cycle of treatment (t2), and either after the second cycle of treatment or at the completion of all treatments (prior to surgery) (t3). The PET/CT images were acquired with a support device built in-house to allow the patient to be in the prone position to facilitate registration with the MRI data. The value of this collection is to provide clinical imaging data for the development and evaluation of quantitative imaging methods for treatment assessment early in the course of therapy for breast cancer.

Date

Updated: 2020-01-10
Published: 2016

Dataset

Motivation

To provide clinical imaging data for the development and evaluation of quantitative imaging methods for treatment assessment early in the course of therapy for breast cancer.

Sampling

Longitudinal PET/CT and quantitative MR images were collected from patients with breast cancer undergoing neoadjuvant therapy. Images were acquired at three time points: prior to the start of treatment (t1), after the first cycle of treatment (t2), and either after the second cycle of treatment or at the completion of all treatments, prior to surgery (t3).